Reduction of Excessive Visceral Fat and Safety with 52-Week Administration of Lipase Inhibitor Orlistat in Japanese: Long-Term Clinical Study

こちらは52週の長期投与での有効性と安全性を試験 【Adv Ther. 2019; 36(1): 217–231.】 Reduction of Excessive Visceral Fat and Safety with 52-Week Administration of Lipase Inhibitor Orlistat in Japanese: Long-Term Clinical Study https://t.co/GjomyPW34l

Study investigates the safety of excessive visceral fat reduction with 52-week administration of lipase inhibitor orlistat in Japanese individuals: https://t.co/Fq694HOli1 #obesity https://t.co/NaDzpCD4th